<div id="readability-page-1"><p><span>Option Care Health (NASDAQ:OPCH - Get Free Report)</span> had its target price hoisted by investment analysts at Bank of America  from $32.00 to $35.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a &#34;buy&#34; rating on the stock. Bank of America's target price would indicate a potential upside of 8.33% from the company's previous close.</p><div><p><span></span><span>Get <strong>Option Care Health</strong> alerts:</span></p></div><ul><li>Option Care Health Stock is Making a Healthy Pullback</li></ul><p>A number of other research analysts have also recently commented on OPCH. Barrington Research  reissued an &#34;outperform&#34; rating and set a $38.00 target price on shares of Option Care Health in a research report on Friday, October 31st. JMP Securities  set a $36.00 price objective on shares of Option Care Health in a research report on Friday, October 31st. Citigroup  reaffirmed an &#34;outperform&#34; rating on shares of Option Care Health in a research report on Friday, October 31st. Cowen began coverage on Option Care Health in a research note on Thursday, October 2nd. They issued a &#34;hold&#34; rating on the stock. Finally, Deutsche Bank Aktiengesellschaft increased their price target on Option Care Health from $31.00 to $36.00 and gave the company a &#34;buy&#34; rating in a report on Tuesday. Ten equities research analysts have rated the stock with a Buy rating and three have issued  a Hold rating to the stock. Based on data from MarketBeat, the stock  has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $35.90.</p><p><b>Read Our Latest Research Report on Option Care Health</b></p><h2>Option Care Health Stock Up 5.6%</h2><p>Shares of NASDAQ:OPCH traded up $1.72 during mid-day trading on Tuesday, hitting $32.31. 1,351,503 shares of the company traded hands, compared to its average volume of 1,917,783. The firm's 50 day simple moving average is $28.32 and its 200 day simple moving average is $29.29. The firm has a market cap of $5.13 billion, a P/E ratio of 25.65, a PEG ratio of 2.11 and a beta of 0.79. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. Option Care Health has a 52-week low of $22.29 and a 52-week high of $35.53. </p><h2>Insider Transactions at Option Care Health</h2><p>In other news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of Option Care Health stock in a transaction on Monday, November 3rd. The shares were bought at an average price of $25.98 per share, with a total value of $987,240.00. Following the acquisition, the director directly owned 413,390 shares in the company, valued at approximately $10,739,872.20. This represents a 10.12% increase in their position. The purchase was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by insiders. </p><h2>Institutional Investors Weigh In On Option Care Health</h2><p>Institutional investors and hedge funds have recently made changes to their positions in the company. USA Financial Formulas acquired a new position in  Option Care Health in the second quarter worth $26,000.  Northwestern Mutual Wealth Management Co. boosted its holdings in shares of  Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock valued at $31,000 after buying an additional 836 shares during the period.  Cornerstone Planning Group LLC raised its stake in  Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company's stock worth $30,000 after acquiring an additional 1,067 shares during the period.  McIlrath &amp; Eck LLC acquired a new stake in  Option Care Health during the second quarter worth about $37,000.  Finally, Brooklyn Investment Group lifted its holdings in  Option Care Health by 186.6% in the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after acquiring an additional 780 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds. </p><h2>Option Care Health Company Profile</h2> (Get Free Report)<p>Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.</p><h2>See Also</h2><ul><li>Five stocks we like better than Option Care Health</li><li>What Are the U.K. Market Holidays? How to Invest and Trade</li><li>UiPath Surges on Earnings: Should Investors Chase the Momentum?</li><li>What is the Nasdaq? Complete Overview with History</li><li>Pure Storage's 27% Fall: Real Opportunity or Deserved Correction?</li><li>What is the Dogs of the Dow Strategy? Overview and Examples</li><li>Oil Prices May Fall to $55 by 2026—Bad News for This Energy ETF</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BDSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BDSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Option Care Health Right Now?</h2><p>Before you consider Option Care Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.</p><p>While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

OPCH

<p>Bank of America raised Option Care Health's price target from $32 to $35, maintaining a "buy" rating. Other analysts also issued positive ratings, with a consensus price target of $35.90. The stock rose 5.6% to $32.31. Institutional investors hold 98.05% of shares. Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares, increasing his position by 10.12%. Option Care Health offers home infusion services in the U.S.</p>

Option Care Health (NASDAQ:OPCH) Price Target Raised to $35.00